Literature DB >> 33449352

Differential Expressions of Ki-67, Bcl-2, and Apoptosis Index in Endometrial Cells of Women With and Without Type II Diabetes Mellitus and Their Correlation with Clinicopathological Variables.

Ceyda Sancakli Usta1, Gulay Turan2, Meryem Hocaoglu3, Cagla Bahar Bulbul4, Kubra Kılıc4, Akin Usta4, Ertan Adalı4.   

Abstract

The objective of this study was to investigate proliferation, apoptosis, and antiapoptotic molecule expression in endometrial cells of reproductive-aged women with and without type II diabetes mellitus (T2D). In this case-control study, a total of 80 endometrial tissue specimens from reproductive-aged women (35 in the proliferative phase and 45 in the secretory phase) were examined. The age and body mass index (BMI) were matched between the groups. Formalin-fixed and paraffin-embedded endometrial tissue samples were used for immunohistochemistry analysis. The presence of proliferation was evaluated with Ki-67 expression, antiapoptotic function of cells was evaluated with Bcl-2 expression, and apoptosis was evaluated with terminal deoxynucleotidyl transferase (TUNEL) immunoreactivity in both the glandular epithelium and stroma of endometrial tissue samples from women with and without T2D. Ki-67 expression in the glandular epithelium and Bcl-2 expression in both the glandular epithelium and stroma were significantly higher in endometrial tissue samples of women in the T2D group than the control group (p = 0.0008, p = 0.0022, and p = 0.0261, respectively). TUNEL immunoreactivity was significantly lower in the glandular epithelium of women in the T2D group than the control group (p = 0.0001). Glandular Ki-67 expression correlated positively with BMI, use of insulin, and hemoglobin A1c level (p = 0.0034, p = 0.0154, and p = 0.0011, respectively). Glandular Bcl-2 expression correlated positively with BMI and duration of T2D (p = 0.0090 and p = 0.0109, respectively). Stromal Bcl-2 expression correlated positively with duration of T2D (p = 0.0069). TUNEL immunoreactivity in the glandular epithelium correlated negatively with duration of T2D (p = 0.0340) and positively with the use of oral antidiabetic agents (p = 0.0226). Compared to age and BMI-matched controls, women with T2D experienced increased cell proliferation and decreased apoptosis in the glandular epithelium and increased antiapoptotic function in both the glandular epithelium and stromal cells. High BMI values in women with diabetes seemed to contribute to increased cell proliferation and increased antiapoptotic function in the glandular epithelium but not the stromal cells.

Entities:  

Keywords:  Apoptosis; Bcl-2; Diabetes mellitus; Endometrial cancer; Ki-67; TUNEL

Mesh:

Substances:

Year:  2021        PMID: 33449352     DOI: 10.1007/s43032-020-00423-z

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  28 in total

Review 1.  Insulin resistance: a significant risk factor of endometrial cancer.

Authors:  Nan Mu; Yuanxi Zhu; Yingmei Wang; Huiying Zhang; Fengxia Xue
Journal:  Gynecol Oncol       Date:  2012-03-23       Impact factor: 5.482

2.  Factors associated with Type I and Type II endometrial cancer.

Authors:  Ashley S Felix; Joel L Weissfeld; Roslyn A Stone; Robert Bowser; Mamatha Chivukula; Robert P Edwards; Faina Linkov
Journal:  Cancer Causes Control       Date:  2010-07-14       Impact factor: 2.506

Review 3.  Endometrial cancer.

Authors:  Philippe Morice; Alexandra Leary; Carien Creutzberg; Nadeem Abu-Rustum; Emile Darai
Journal:  Lancet       Date:  2015-09-06       Impact factor: 79.321

Review 4.  Global aetiology and epidemiology of type 2 diabetes mellitus and its complications.

Authors:  Yan Zheng; Sylvia H Ley; Frank B Hu
Journal:  Nat Rev Endocrinol       Date:  2017-12-08       Impact factor: 43.330

5.  Diabetes mellitus and risk of endometrial cancer: a meta-analysis.

Authors:  E Friberg; N Orsini; C S Mantzoros; A Wolk
Journal:  Diabetologia       Date:  2007-05-03       Impact factor: 10.122

6.  A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer.

Authors:  Marc J Gunter; Donald R Hoover; Herbert Yu; Sylvia Wassertheil-Smoller; Joann E Manson; Jixin Li; Tiffany G Harris; Thomas E Rohan; Xiaonan Xue; Gloria Y F Ho; Mark H Einstein; Robert C Kaplan; Robert D Burk; Judith Wylie-Rosett; Michael N Pollak; Garnet Anderson; Barbara V Howard; Howard D Strickler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-04       Impact factor: 4.254

Review 7.  Role of progesterone in endometrial cancer.

Authors:  J Julie Kim; Eloise Chapman-Davis
Journal:  Semin Reprod Med       Date:  2010-01-26       Impact factor: 1.303

8.  The effect of diabetes on the risk of endometrial Cancer: an updated a systematic review and meta-analysis.

Authors:  Lotfolah Saed; Fatemeh Varse; Hamid Reza Baradaran; Yousef Moradi; Sorour Khateri; Emilie Friberg; Zaher Khazaei; Saeedeh Gharahjeh; Shahrzad Tehrani; Amir-Babak Sioofy-Khojine; Zahra Najmi
Journal:  BMC Cancer       Date:  2019-05-31       Impact factor: 4.430

9.  Body mass, diabetes and smoking, and endometrial cancer risk: a follow-up study.

Authors:  K Lindemann; L J Vatten; M Ellstrøm-Engh; A Eskild
Journal:  Br J Cancer       Date:  2008-03-25       Impact factor: 7.640

10.  Association between diabetes, diabetes treatment and risk of developing endometrial cancer.

Authors:  J Luo; S Beresford; C Chen; R Chlebowski; L Garcia; L Kuller; M Regier; J Wactawski-Wende; K L Margolis
Journal:  Br J Cancer       Date:  2014-07-22       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.